The Enabling Technologies Consortium™ is comprised of pharmaceutical and biotechnology companies collaborating on issues related to pharmaceutical chemistry, manufacturing, and control with the goal of identifying, evaluating, developing, and improving scientific tools and techniques that support the efficient development and manufacturing of pharmaceuticals.
ETC has issued a Request for Information on UHPLC-DAD Spectral Deconvolution. Questions on the RFI are due November 5, and responses are due December 3.
Learn about ETC’s work in solid dosing technologies in a newly published manuscript on Collaborative Evaluation of Commercially Available Automated Powder Dispensing Platforms for High Throughput Experimentation in Pharmaceutical Applications. Matthew N. Bahr et al, Organic Process Research & Development. 9 October 2018 (web publication).
Read the Enabling Technologies Consortium Summer 2018 Newsletter for updates on our projects, events, and publications.
If you are interested in joining our Consortium or learning more, please contact us.
ETC™ regularly issues Requests for Information to solicit interest in collaborating on high-value opportunities to deliver innovative technologies with a compelling business case. See our current opportunities.